Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of curettage after methotrexate in cesarean scar pregnancy
IRCT20130626013777N4Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methotrexate in cesarean scar pregnancy (CSEP) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Hemoglobin levels, Need for laparotomy and 4 more. Started Feb 2023; status: completed.
02
Drugs
methotrexate
03
Conditions
cesarean scar pregnancy (CSEP)
Beyond the preview
Go deeper on IRCT20130626013777N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130626013777N4.